<style face="normal" font="default" size="100%">Diabetes type 2 CV outcome trials. Time to transition from non-inferiority safety to superiority efficacy trials? Session- Diabetes Outcome Trials. Transitioning to CV efficacy Trials [invited speaker]</style>

Drupal-Bibcite